Cervical Intraepithelial Neoplasia
Back to Diseases List
Associated Genetic Biomarkers
NCI Definition: Squamous or glandular intraepithelial neoplasia that affects the cervical mucosal epithelium. There is no evidence of stromal invasion. According to the degree of cellular atypia and the associated architectural changes, it is classified as low or high grade. 
There are 4 clinical trials for cervical intraepithelial neoplasia, of which 2 are open and 2 are completed or closed. Of the trials that contain cervical intraepithelial neoplasia as an inclusion criterion, 3 are phase 1 (1 open) and 1 is phase 2 (1 open).
CDKN2A, HPV, and HLA-A*02:01 are the most frequent gene inclusion criteria for cervical intraepithelial neoplasia clinical trials .
Hpv-16 e7 tcr expressing t-cells, electroporation, and pngvl4acrte6e7l2 dna vaccine are the most common interventions in cervical intraepithelial neoplasia clinical trials.
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.
3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.